According to the notice, the relevant expenses incurred by the insured in designated primary medical institutions are paid according to the current regulations of the overall planning area, and the expenses for purchasing testing reagents in designated retail pharmacies can be paid by personal accounts.
Citizen Hou:
With the (antigen detection) kit, you can swipe the medical insurance card to test at home, which is very convenient.
Wu Yu, a staff member of Personal Rights Service Department of Jinan Medical Insurance Center:
At present, employees and insured persons in Jinan can use personal accounts of medical insurance to buy antigen detection kits in designated retail pharmacies, which is convenient for insured persons in need to conduct self-tests. At the same time, timely settle medical insurance funds with pharmacies to ensure the normal operation of designated retail pharmacies.
If the antigen test is positive, it should be reported immediately.
According to National Health Commission's introduction, residents do not need to put on record to buy products tested by self-test antigen, but if the antigen result is positive, regardless of whether there are symptoms such as respiratory tract and fever, residents should immediately report to their communities (towns and villages), and the communities (towns and villages) will contact the emergency center and transfer them to medical institutions with fever clinics for nucleic acid testing. All used cotton swabs, test tubes and test cards must be packed in sealed plastic bags, taken away by the door-to-door staff and handed over to medical institutions for treatment as medical waste.
Antigen detection can not replace nucleic acid detection as a diagnostic standard.
Compared with nucleic acid detection, antigen detection does not need professional machines and special places, and results can be obtained in a short time. According to experts, the sensitivity of antigen detection reagents approved in China is 75%-98%, and the specificity is 95%-99%. In other words, there may be some false positives and false negatives. Therefore, antigen detection can not replace nucleic acid detection as the "gold standard" for diagnosis at present. Experts suggest that, according to the characteristics of antigen testing, the general population in low-prevalence areas of COVID-19 should not be tested for COVID-19 antigen. These people have no symptoms and have no relevant epidemiological residence history.